Anal human papillomavirus (HPV) infection is common among women and the cause of most anal malignancies. The incidence of anal cancer has been increasing among U.S. women; yet few co-factors for the natural history of anal HPV infection have been identified. We examined the hypothesis that plasma carotenoid, retinol, and tocopherol concentrations are associated with the acquisition and clearance of anal HPV infection in a cohort of 279 Hawaiian residents followed at 4-month intervals for a mean duration of 16 months. At each visit, interviews were conducted and biological specimens were obtained, including anal cell specimens for HPV DNA detection and genotyping, and a fasting blood sample to measure 27 micronutrients. Cohort participants acquired 189 anal HPV infections, 113 of which cleared during the study period. The most frequently acquired HPV genotypes were HPV-52, 53, 84, and 16. Women in the highest quartile of trans-zeaxanthin, trans-anhydro-lutein, trans-, cis-, and total β-carotene had significant 43-50% reduction in the risk of acquisition of any HPV infection compared to women in the lowest quartile. Few associations were observed between micronutrient levels and clearance of transient (≤150 days) anal HPV infections. However, clearance of persistent (>150 days) infections was associated with higher levels of β + γ-tocopherol and lower levels of carotenoids and retinol. Our findings suggest that several carotenoids can reduce the risk and clearance of anal HPV infections that contribute to anal cancer.
INTRODUCTION
Anal cancer is an uncommon malignancy, occurring at a rate of ~1.5 per 100,000 in the US, but its incidence has increased substantially during the past several decades in the US and other countries (1) (2) (3) . The rate of invasive anal squamous cell carcinoma increased by 1.7% per year, and in situ tumors increased by 2.9% per year between 1973 and 2005 (1), but the basis for this increase is not well understood. Anal cancer is one of the few malignancies without a known hormonal etiology that is more frequent among women than among men. In the US, there were an estimated 5,290 new cases of anal cancer in 2009, with 3,190 cases occurring in women and 2,100 cases occurring in men (4) .
During the past decade, epidemiological studies have shown that the majority of anal cancers in both sexes are associated with human papillomavirus (HPV) (5) , the most common sexually-transmitted infection (6) . It is unknown why women are at greater risk of squamous cell anal cancer and are more likely to have HPV-positive anal cancer than men (1) . Risk factors for anal malignancies in females include a history of other HPVassociated diseases (7, 8) , anal receptive intercourse (9, 10) , tobacco smoking (10) , and multiple sexual partners (10, 11) . However, little is known regarding the natural history of anal HPV, particularly the correlates of HPV acquisition and clearance among women.
In some populations of women, the prevalence of anal HPV infection may be at least as high as the prevalence of cervical HPV infection (12) (13) (14) , but the viral infection appears to clear far more rapidly in the anus than in the cervix (15) . The biological basis for the relatively rapid clearance of anal HPV infection compared to cervical HPV infection has Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Copyright © 2010 American Association for Cancer Research times, and placed in 1.0 mL buffered medium (Digene Corp., Gaithersburg, MD).
Women entering the cohort were asked to return every four months for repeat examination and testing.
A study questionnaire was administered by the study interviewer after each clinical examination. The baseline questionnaire included demographic and sexual activity data, and histories of tobacco and alcohol use. A more detailed interview, conducted during the second visit after a four-month interval, included gynecological, menstrual, reproductive and sexual histories, hormone use, medical history, history of sexually transmitted infections, and income. Information covered in the baseline questionnaire (sexual activity, tobacco and alcohol use) was also updated. The questionnaire used at subsequent interviews was modified slightly for use during the follow-up period; questions included changes in sexual and reproductive information during the period since the last clinic visit.
Laboratory Analysis
Detection and genotyping of HPV. HPV DNA was extracted from exfoliated anal and cervical cell specimens using commercial reagents (Qiagen Inc, Valencia CA).
Specimens were analyzed for presence of HPV DNA by PCR using a modified version of the PGMY09/PGMY11 primer system (23 (26) . HPV-positive specimens subsequently found to be negative in the genotyping assay were considered unclassified HPV-positive specimens. All specimens were also tested for the human β-globin gene as an internal control for sample sufficiency. The 163 of 1257 anal specimens which tested negative for β-globin were considered insufficient and were excluded from analyses.
Micronutrient analysis.
Blood was drawn at the clinic into heparin tubes after a 10-12 hour fast and was used to determine plasma micronutrient levels of both cis and trans forms of lutein/zeaxanthin, α-, β-and total cryptoxanthin, trans and cis forms of lycopene, α-carotene, trans and cis forms of β-carotene, total carotene, retinol, α-, γ-and δ-, and total tocopherol. Total nutrient levels were determined by adding up all individual Sample extracts were analyzed by reversed-phase HPLC with photo diode array detection (27, 28) . Absorption spectra and retention times for each peak were compared to those of known authentic standards. Briefly, under subdued light 0.5 ml of thawed plasma was vortexed by hand for at least 1 minute with 0.5 ml of ethanol containing 0.3 mg/L nbutyl-, β-apo-8′-carotenoate (as an internal standard for carotenoids), 1.0 mg/L retinyl laurate (as an internal standard for retinoids), 6.0 mg/L tocol (as an internal standard for tocopherols), and 250 mg/L butylated hydroxytoluene (as preservative) followed by extraction with hexane. After drying the hexane extracts with nitrogen at ambient temperature and redissolving it in mobile phase, 0.01 mL were subjected to isocratic C18 HPLC analysis. The high quality of all laboratory analyses was assured by participation Institute for Standards and Technologies (Gaithersburg, Maryland) and by the inclusion of pooled plasma from 8 healthy volunteers to measure variation during the three month period between study visits, which showed a coefficient of variation for all analytes between 4 and 10%. The intraclass correlation coefficients were above 0.6 for all but three micronutrients (29) , and all of the micronutrients were detectable in each plasma sample (28) .
Statistical Analysis
Of infection detected at any time a woman was at risk for acquisition or clearance of the index anal infection. Such adjustment was conducted to rule out the possibility that the observed findings were primarily driven by an association of micronutrients with HPV infection in the cervix, rather than the anus. All analyses were repeated for anal infections with no concordant cervical infection, yielding similar results (data not shown). Days since study entry (for acquisition) and days since infection acquisition (for clearance)
were used as the time metrics. Adjustment variables were selected among baseline demographic and behavioral risk factors that were significantly associated with acquisition or clearance of anal HPV in our cohort (15, 22) . These risk factors included age, current tobacco smoking, current practice of anal sex, and history of pregnancy during lifetime. We additionally adjusted for the amount of time a blood sample was kept frozen between blood draw and laboratory analysis. The inclusion of other risk factors, such as the number of sexual partners, in the models did not result in over 10% change in the parameter estimates (30) , nor in a significantly better fit according to the likelihood ratio test. We additionally checked for correlation among the micronutrient levels. While isoforms of the same micronutrient were strongly correlated (≥ 0.8), correlation between different micronutrients was moderate to low (0-0.6; data not shown).
Hazard ratios and 95% confidence intervals were calculated for micronutrient levels divided into quartiles and represented by three indicator variables, using the lowest quartile as a reference category. The Wald χ infected with more than one HPV type at one time. We assigned a separate infection path to every genotype detected. Because each subject was allowed to experience more than one clearance event throughout the course of the study, we used a robust sandwich variance estimate (31), aggregated over subjects, to prevent artificially deflated standard errors and confidence interval estimates. Time-dependent indicator variables, measured at every visit for each study subject, were used to account for the presence of a concordant cervical HPV infection and the presence of anal infection with multiple HPV types.
The proportional hazard assumption for Cox models was verified by plotting scaled Schoenfeld residuals against time to HPV acquisition or clearance (32) . Although the assumptions were not significantly violated, there was evidence that the effect of some micronutrients on HPV clearance varied with time. Therefore, we adopted a change-point estimation approach for clearance models (33, 34) 
RESULTS
Cohort participants completed a total of 1090 clinical visits, with a mean of 4 visits per woman and an average of 1.3 years follow-up ( Table 1 ). The cohort composition was multiethnic and participants were 38 years of age, on average, at cohort entry. Only 14% of women were current tobacco smokers, and 7% reported history of anal sex. About two thirds of the cohort had a history of pregnancy, and 107 women had prevalent anal HPV infections. A total of 189 incident anal HPV infections were observed during the follow-up period. The most frequently acquired HPV genotypes were HPV-52, 53, and 84, followed by HPV-16, 56, and 62 ( Figure 1 ). We have previously reported on the distribution of micronutrient levels in the same group of women (29) .
Higher circulating carotenoid levels were generally associated with a reduced risk of anal HPV acquisition (Table 2 ). Significant inverse associations of incident anal HPV with carotenoid levels were observed for trans-zeaxanthin, total β-carotene, and total carotenoids. Women in the highest quartile of trans-zeaxanthin and total β-carotene had The natural history of anal malignancy has close parallels to cervical malignancy through the initial development of a precursor dysplastic condition, 'anal intraepithelial neoplasia', followed by cancer (9) . In our cohort, the acquisition rate for anal HPV infection was higher than the acquisition rate for cervical HPV infection, but clearance was more rapid, suggesting more efficient innate and adaptive immune responses in the anus than the cervix (36) . The immunomodulatory effects of vitamin E and the carotenoids are well-documented (reviewed in reference 37), and include an influence on soluble immune mediators, cytokine production and lymphocyte counts. Vitamin E supplementation has been reported to enhance macrophage function and CD4 T cell activity, and down-regulate inflammatory cytokines (e.g., IL-1, IL-6, TNF). Through its antioxidant function, vitamin E may protect lipid membranes of immune cells in the presence of an inflammatory environment, preserving cellular function (37) . However, large doses of vitamin E may also have harmful effects on the immune system, including depressing the bactericidal activity of phagocytes (38, 39) and increasing the risk of pneumonia in some subgroups of smokers (40) . Our findings were specific to γ-tocopherol: we found no influence of α-tocopherol on anal HPV clearance. The antiinflammatory activity of γ-tocopherol, including trapping of reactive nitrogen species, and the inhibition of cyclooxygenase activity and eicosanoid production, is thought to be greater than that of α-tocopherol, providing a potential explanation for our findings regarding this form of tocopherol (41).
Our finding that carotenoids reduced the risk of both HPV acquisition and HPV Strengths of the present study include multiple measurements of micronutrient levels over a period of time, which provided us with a better understanding of variation in participants' micronutrient levels over time. A number of investigators (27, 29, 45) report substantial intra-individual variability in circulating micronutrient levels, suggesting that more than one blood sample is required to accurately assess micronutrient concentrations.
A further advantage of our study design is simultaneous collection of cervical and anal samples, which allowed us to account for the presence of cervical HPV infection in our analyses of anal HPV acquisition and clearance.
Potential limitations of this study include a modest sample size, which limited the Adjusted for age at first visit; current tobacco smoking status; current practice of anal sex; history of pregnancy over lifetime; period of time the blood was kept frozen, from blood draw until laboratory analysis; coinfection in the anus with other HPV genotypes; cervical infection with the index HPV type. ‡ CI, confidence interval. §
The P for trend is based on a Wald statistic for a trend variable assigned the median for the appropriate quartile. **Statistically significant after Bonferroni correction for multiple comparisons.
